wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41207230-16967FE1-4A25-4D6E-B32D-26C44838276B
Q41207230-16967FE1-4A25-4D6E-B32D-26C44838276B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41207230-16967FE1-4A25-4D6E-B32D-26C44838276B
The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus.
P2860
Q41207230-16967FE1-4A25-4D6E-B32D-26C44838276B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41207230-16967FE1-4A25-4D6E-B32D-26C44838276B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
99b29a65d1ffcc8bedfbb131a4bdb35feba1d6a2
P2860
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.